Barclays Maintains Overweight on Centene, Lowers Price Target to $91
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Andrew Mok maintains an Overweight rating on Centene (NYSE:CNC) but lowers the price target from $97 to $91.
October 29, 2024 | 12:46 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Barclays analyst Andrew Mok maintains an Overweight rating on Centene but lowers the price target from $97 to $91, indicating a slightly less optimistic outlook.
The Overweight rating suggests continued confidence in Centene's performance, but the lowered price target indicates a tempered outlook. This mixed signal may result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100